Top

Published in:

Open Access 01-12-2018 | Original Article

Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts

Authors: Tomasz Kaczmarzyk, Konrad Kisielowski, Rafał Koszowski, Magdalena Rynkiewicz, Ewa Gawełek, Karolina Babiuch, Anna Bednarczyk, Bogna Drozdzowska

Published in: Clinical Oral Investigations | Issue 9/2018

Abstract

Objectives

Odontogenic keratocyst (OKC) presents considerable variation in aggressiveness and propensity for recurrence, yet hitherto, no explicit clinicopathological features have been determined to clearly demonstrate the potential for relapse. This retrospective study aims to investigate the prognostic relevance of various clinicopathological features as well as immunoexpression of COX-2, bcl-2, PCNA, and p53 in sporadic OKC.

Materials and methods

Among 41 patients with OKC treated by enucleation, the frequency of recurrence for various clinicopathological features as well as immunoexpression for COX-2, bcl-2, PCNA, and p53 was evaluated.

Results

The mean follow-up was 8.49 years, and recurrences were ascertained in 29.27% of cases. We found significant differences between recurrent and non-recurrent cysts in terms of multilocularity (P = 0.029), cortical perforation (P = 0.001), and lesion size (P < 0.001). Hazard risk for the recurrence was 3.362 (95% CI 1.066–10.598) for multilocular cysts, 7.801 (95% CI 2.1–28.985) for evidence of cortical perforation, and 1.004 (1.002–1.006) for 1 mm² of lesion size on panoramic radiographs. We also found that immunoexpression of PCNA significantly correlates with the radiographic evidence of cortical perforation (P = 0.048) and that there is significant positive correlation between expression of COX-2 and bcl-2 (P = 0.001) as well as significant negative correlation between immunoexpression of COX-2 and age (P = 0.002). None of the other analyzed factors were associated with the recurrence.

Conclusions

Larger size, multilocularity, and cortical perforation in sporadic OKC may be correlated with the relapse.

Clinical relevance

Immunohistochemical analyses of COX-2, bcl-2, PCNA, and p53 lack prognostic utility in sporadic OKC.

Philipsen HP (2005) Keratocystic odontogenic tumour. In: Barnes L, Evenson JW, Reichart P, Sidransky D (eds) Pathology and genetics of head and neck tumours. IARC Press, Lyon, pp 306–307

Speight P, Devilliers P, Li TJ, Odell EW, Wright JM (2017) Odontogenic keratocyst. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO classification of head and neck tumours. IARC Press, Lyon, pp 235–236

Wright JM, Vered M (2017) Update from the 4th edition of the World Health Organization classification of head and neck tumours: odontogenic and maxillofacial bone tumours. Head Neck Pathol 11:68–77CrossRef

Pitak-Arnnop P (2010) Enucleation of keratocystic odontogenic tumours: study interpretation, technical refinement and future research. Clin Oral Invest 14:719–721CrossRef

Antonoglou GN, Sȧndor GK, Koidou VP, Papageorgiou SN (2014) Non-syndromic and syndromic keratocystic odontogenic tumours: systematic review and meta-analysis of recurrences. J Craniomaxillofac Surg 42:e364-e371CrossRef

Kaczmarzyk T, Mojsa I, Stypulkowska J (2012) A systematic review of the recurrence rate for keratocystic odontogenic tumour in relation to treatment modalities. Int J Oral Maxillofac Surg 41:756–767CrossRef

Al-Moraissi EA, Dahan AA, Alwadeai MS, Oginni FO, Al-Jamali JM, Alkhutari AS, Al-Tairi NH, Almaweri AA, Al-Sanabani JS (2017) What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor?: a large systematic review and meta-analysis. J Craniomaxillofac Surg 45:131–144CrossRef

Kuroyanagi N, Sakuma H, Miyabe S, Machida J, Kaetsu A, Yokoi M, Maeda H, Warnakulasuriya S, Nagao T, Shimozato K (2009) Prognostic factors for keratocystic odontogenic tumor (odontogenic keratocyst): analysis of clinico-pathologic and immunohistochemical findings in cysts treated by enucleation. J Oral Pathol Med 38:386–392CrossRef

Ibrahim N, Nazimi AJ, Ajura AJ, Nordin R, Latiff ZA, Ramli R (2016) The clinical features and expression of bcl-2, cyclin D1, p53, and proliferating cell nuclear antigen in syndromic and nonsyndromic keratocystic odontogenic tumor. J Craniofac Surg 27:1361–1366CrossRef

10.

el Murtadi A, Grehan D, Toner M, McCartan BE (1996) Proliferating cell nuclear antigen staining in syndrome and nonsyndrome odontogenic keratocyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:217–220CrossRef

11.

Mendes RA, Carvalho JFC, van der Waal I (2009) An overview on the expression of cyclooxygenase-2 in tumors of the head and neck. Oral Oncol 45:e124-e128CrossRef

12.

Mendes RA, Carvalho JFC, van der Waal I (2011) Potential relevance of cyclooxygenase-2 expression in keratocystic odontogenic tumours—an immunohistochemical study. J Oral Pathol Med 40:497–503CrossRef

13.

Wang J, Zhang X, Ding X, Xing S, Li H, Zang W, Wang L, Wu H (2013) Cyclooxygenase-2 expression in keratocystic odontogenic tumour decreased following decompression. Mol Clin Oncol 1:982–986CrossRef

14.

Piattelli A, Fioroni M, Rubini C (1998) Differentiation of odontogenic keratocysts from other odontogenic cysts by the expression of bcl-2 immunoreactivity. Oral Oncol 34:404–407CrossRef

15.

Ogden GR, Chisholm DM, Kiddie RA, Lane DP (1992) p53 protein in odontogenic cyst: increased expression in some odontogenic keratocysts. J Clin Pathol 45:1007–1010CrossRef

16.

Agaram NP, Collins BM, Barnes L, Lomago D, Aldeeb D, Swalsky P, Finkelstein S, Hunt JL (2004) Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med 128:313–317PubMed

17.

Medes RA, Carvalho JFC, van der Waal I (2010) Characterization and management of the keratocystic odontogenic tumor in relation to its histopathological and biological features. Oral Oncol 46:219–225CrossRef

18.

Leonardi R, Perrotta RE, Crimi S, Matthews JB, Barbato E, dos Santos JN, Rusu M, Bufo P, Bucci P, Pannone G (2015) Differential expression of TLR3 and TLR4 in keratocystic odontogenic tumor (KCOT): a comparative immunohistochemical study in primary, recurrent, and nevoid basal cell carcinoma syndrome (NBCCS)-associated lesions. J Craniomaxillofacial Surg 43:733–737CrossRef

19.

Yagyuu T, Kirita T, Sasahira T, Moriwaka Y, Yamamoto K, Kuniyasu H (2008) Recurrence of keratocystic odontogenic tumor: clinicopathological features and immunohistochemical study of the Hedgehog signaling pathway. Pathobiology 75:171–176CrossRef

20.

Chrcanovic BR, Gomez RS (2017) Recurrence probability for keratocystic odontogenic tumors: an analysis of 6427 cases. J Craniomaxillofac Surg 45:244–251CrossRef

21.

Avril L, Lombardi T, Ailianou A, Burkhardt K, Varoquaux A, Scolozzi P, Becker M (2014) Radiolucent lesions of the mandible: a pattern-based approach to diagnosis. Insights Imaging 5:85–101CrossRef

22.

Finkelstein MW, Hellstein JW, Lake KS, Vincent SD (2013) Keratocystic odontogenic tumor: a retrospective analysis of genetic, immunohistochemical and therapeutic features. Proposal of a multicenter clinical survey tool. Oral Surg Oral Med Oral Pathol Oral Radiol 116:75–83CrossRef

23.

Forssel K, Forssel H, Kahnberg KE (1988) Recurrence of keratocysts. A long-term follow-up study. Int J Oral Maxillofac Surg 17:25–28CrossRef

24.

Tekkesin MS, Mutlu S, Olgac V (2011) The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. Head Neck Pathol 5:248–253CrossRef

25.

de Matos FR, de Moraes M, das Neves Silva EB, Galvão HC, de Almeida Freitas R (2013) Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors. J Oral Maxillofac Surg 71:1886–1892CrossRef

26.

Naruse T, Yamashita K, Yanamoto S, Rokutanda S, Matsushita Y, Sakamoto Y, Sakamoto H, Ikeda H, Ikeda T, Asahina I, Umeda M (2017) Histopathological and immunohistochemical study in keratocystic odontogenic tumors: predictive factors of recurrence. Oncol Lett 13:3487–3493CrossRef

27.

Myoung H, Hong SP, Hong SD, Lee JI, Lim CY, Choung PH, Lee JH, Choi JY, Seo BM, Kim MJ (2001) Odontogenic keratocyst: review of 256 cases for recurrence and clinicopathologic parameters. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:328–333CrossRef

28.

Partridge M, Towers JF (1987) The primordial cyst (odontogenic keratocyst): its tumour-like characteristics and behaviour. Br J Oral Maxillofac Surg 25:271–279CrossRef

29.

Pavelić B, Katunarić M, Segović S, Karadole MC, Katanec D, Saban A, Puhar I (2014) The incidence of satellite cysts in keratocystic odontogenic tumors. Coll Antropol 38:269–273PubMed

30.

Mendes RA, Carvalho JFC, van der Waal I (2011) A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111:333–339CrossRef

31.

Yang B, Jia L, Guo Q, Ren H, Hu Y, Xie T (2016) Clinicopathological and prognostic significance of cyclooxygenase-2 expression in head and neck cancer: a meta-analysis. Oncotarget 7:47265–47277

32.

Shear M (2002) The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2: proliferation and genetic studies. Oral Oncol 38:323–331CrossRef

33.

Katase N, Nagatsuka H, Tsujigiwa H, Gunduz M, Tamamura R, Pwint HP, Rivera RS, Nakajima M, Naomoto Y, Nagai N (2007) Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor. J Oral Pathol Med 36:550–554CrossRef

34.

Lo Muzio L, Staibano S, Pannone G, Bucci P, Nocini PF, Bucci E, De Rosa G (1999) Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res 78:1345–1353CrossRef

35.

Mohan S, Epstein JB (2003) Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral Oncol 39:537–546CrossRef

36.

Vered M, Peleg O, Taicher S, Buchner A (2009) The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts. J Oral Pathol Med 38:597–604CrossRef

37.

Kolář Z, Geierová M, Bouchal J, Pazdera J, Zbořil V, Tvrdý P (2006) Immunohistochemical analysis of the biological potential of odontogenic keratocysts. J Oral Pathol Med 35:75–80CrossRef

38.

Pich A, Chiusa L, Navone R (2004) Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 15:1319–1329CrossRef

39.

Shahela T, Aesha S, Ranganathan K, T R, Roa KUD, Joshua E, Ahmed AS, Chittamsetty H (2013) Immunohistochemical expression of PCNA in epithelial linings of selected odontogenic lesions. J Clin Diagn Res 7:2615–2618

40.

Seyedmajidi M, Nafarzadeh S, Siadati S, Shafaee S, Bijani A, Keshmiri N (2013) p53 and PCNA expression in keratocystic odontogenic tumors compared with selected odontogenic cysts. Int J Mol Cell Med 2:185–193PubMedPubMedCentral

41.

Ball VA, Righi PD, Tejada E, Radpour S, Pavelic ZP, Gluckman JL (1997) p53 immunostaining of surgical margins as a predictor of local recurrence in squamous cell carcinoma of the oral cavity and oropharynx. Ear Nose Throat J 76:818–823PubMed

42.

Gröbe A, Hanken H, Al-Dam A, Cachovan G, Smeets R, Krohn A, Clauditz T, Grob T, Simon R, Sauter G, Kluwe L, Heiland M, Blessmann M (2014) P53 immunohistochemical expression does not correlate with clinical features in 207 carcinomas of the oral cavity and in the head and neck region. Clin Oral Invest 18:211–217CrossRef

43.

Razavi SM, Chalice S, Torabinia N (2014) Investigation of clinicopathological parameters alongside with p53 expression in primary and recurrent keratocystic odontogenic tumours. Malays J Pathol 36:105–113PubMed

44.

Lombardi T, Odell EW, Morgan PR (1995) p53 immunohistochemistry of odontogenic keratocysts in relation to recurrence, basal-cell budding and basal-cell naevus syndrome. Arch Oral Biol 40:1081–1084CrossRef

45.

Gurgel CA, Ramos EA, Azevedo RA, Sarmento VA, da Silva Carvalho AM, dos Santos JN (2008) Expression of Ki-67, p53 and p63 proteins in keratocystic odontogenic tumours: an immunohistochemical study. J Mol Histol 39:311–316CrossRef

Title: Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts
Authors: Tomasz Kaczmarzyk
Konrad Kisielowski
Rafał Koszowski
Magdalena Rynkiewicz
Ewa Gawełek
Karolina Babiuch
Anna Bednarczyk
Bogna Drozdzowska
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: Clinical Oral Investigations / Issue 9/2018
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-018-2400-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Please log in to get access to this content

Other articles of this Issue 9/2018

Inflammatory serum markers up to 5 years after comprehensive periodontal therapy of aggressive and chronic periodontitis

Reduced salivary amylase activity in metabolic syndrome patients with obesity could be improved by treatment with a dipeptidyl peptidase IV inhibitor

Determination of nicotine content in teeth submitted to prophylaxis and in-office bleaching by gas chromatography–mass spectrometry (GC-MS)

The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic review

Assessing abrasion of orthodontic surface sealants using a modified ophthalmic optical coherence tomography device

Evaluation of the chemopreventive effects of Ankaferd Bloodstopper in 7,12-dimethylbenz[a]anthracene-induced oral epithelial dysplasia